Merck KGaA : Some light at the end of the tunnel in Process solutions, Healthcare strong
>Light at the end of the tunnel in process solutions - Process solutions is experiencing strong headwind from destocking of biopharma companies. Merck expects to see the trough during the third quarter and some normalisation of order intake in the first half of 2024. We factor in the reduced expectations for Process solutions and are now forecasting an organic decline of 11.5% for FY 2023. While we expect Science and Lab solutions to be the resilient anchor with 1.5% ...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.